We deliver customized Volume slogan Quality

About Us

Our Journey

Our Journey

"Your preferred partner for advance molecule - APIs, Intermediates & Semi finished formulations"

Please visit our stall in CPhI Korea From August 28th 2018 to August 30th 2018, COEX,Seoul,Korea, Hall Number D , Stand Number E19.                         Please visit our stall in CPhI middle East and Africa Hall No 1, Stand No L50 From 3rd Sep 2018 to 5th sep 2018, ADNEC,ABU DHABI,UAE.                         Please visit our stall in CPhI World Wide From October 9th 2018 to October 11th 2018,FEMA,Feria de Madrid,Spain, Hall Number H7 , Stand Number F72.                        

Metrochem API established in 2004 at Hyderabad is the largest manufacturer of Proton Pump Inhibitors (PPI’s) in India currently..

Below is a  brief journey of  Metrochem API’s  growth path.

  • 2004- Started with one facility for two APIs.
  • 2005- Started intermediates manufacturing facility for backward integration.
  • 2006- Started a Pelletization facility for forward integration.
  • 2007- Four GMP facilities manufacturing more than 10 API's.
  • 2008- Started  Synergene Active Ingredients Pvt. Ltd an associate company certified by WHO GMP.
  • 2009 - API facility receives Japanese accreditation for Lansoprazole .
  • 2010- Total of Six manufacturing facilities Producing  world class products.
  • 2011- Inaugurated new state of the art R&D center to support our future growth plans. All affiliated departments likeQA,RA& R&D under one roof at this development center.
  • 2012- Initiated a large scale greenfield USFDA approvable facility under implementation for vertical integration of API's  & Intermediates, with clean room reactions.
  • 2013- API facility receives WHO-GMP ,USFDA & COFEPRIS.
  • 2014. Trial Production started at Vizag facility.
  • 2014- Initiated new green field project for forward integration into finished dosage forms , expected to be operational by end of 2015.
  • 2014- KFDA authorities already inspected both the facilities (API 's& Pellets ), we  are waitingcertificate.
  • 2014- Positive revenue growth year - on – year from USD 0 to USD 41 million
  • 2015- Moving towards EUGMP, MHRA & TGA.